10x Genomics
TXG
TXG
255 hedge funds and large institutions have $3.75B invested in 10x Genomics in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 81 increasing their positions, 99 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
25% less capital invested
Capital invested by funds: $4.98B → $3.75B (-$1.23B)
33% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 49
Holders
255
Holding in Top 10
4
Calls
$41.1M
Puts
$8.98M
Top Buyers
| 1 | +$237M | |
| 2 | +$37.4M | |
| 3 | +$24.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$18.5M |
Top Sellers
| 1 | -$67.5M | |
| 2 | -$58.5M | |
| 3 | -$36.7M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$25M |
| 5 |
GIM
Generation Investment Management
London,
United Kingdom
|
-$24.8M |